Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

Clinical and Experimental Allergy

Volumn 39, Issue 3, 2009, Pages 394-400

  Horak, F ^a   Jaeger, S ^a   Worm, M ^b   Melac, M ^c   Didier, A ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Stallergenes SA   (France)

^d SERVICE DE PNEUMOLOGIE   (France)

Author keywords

Allergic rhinoconjunctivitis; Grass pollen allergy; Optimal dosage; Pollen peak; Pollen season; Pre seasonal treatment; Sublingual immunotherapy; Sublingual tablet

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL PAIN; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MOUTH DISEASE; MOUTH ITCHING; MOUTH SWELLING; OPTIMAL DRUG DOSE; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOCONJUNCTIVITIS; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; URTICARIA;

ADOLESCENT; ADULT; ANTIGENS, PLANT; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; POACEAE; POLLEN; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58849093549     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03153.x     Document Type: Article

References (14)

1. Asher MI, Montefort S, Bjorksten B et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006 368 : 733 43.
2. D'Amato G, Cecchi L, Bonini S et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007 62 : 976 90.
3. Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007 62 : 301 9.
4. Gioulekas D, Papakosta D, Damialis A, Spieksma F, Giouleka P, Patakas D. Allergenic pollen records (15 years) and sensitization in patients with respiratory allergy in Thessaloniki, Greece. Allergy 2004 59 : 174 84.
5. Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006 61 (Suppl. 81) : 20 3.
6. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
7. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 802 9.
8. Dahl R, Kapp A, Colombo G et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 118 : 434 40.
9. Didier A, Malling HJ, Worm M et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007 120 : 1338 45.
10. Pradalier A, Basset D, Claudel A et al. Sublingual-swallow immunotherapy (SLIT) with a standardized fivegrass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999 54 : 819 28.
11. Larsen T, Poulsen L, Melac M, Combebias A, Andre C, Malling H. Safety and tolerability of grass pollen tablets in sublingual immunotherapy (SLIT): a phase 1 study. Allergy 2006 61 : 1173 6.
12. Moingeon P, Hrabina M, Bergmann KC et al. Specific immunotherapy for common grass pollen allergies: pertinence of a five grass pollen vaccine. Int Arch Allergy Immunol 2008 146 : 338 42.
13. Didier A, Melac M, Montagut A, Lheritier-Barrand M, Tabar A, Worm M. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy 2008 in press.
14. Calderon MA, Birk AO, Andersen JS, Durham SR. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy 2007 62 : 958 61.